Gemfibrozil improves abnormalities of lipid metabolism in patients on continuous ambulatory peritoneal dialysis: the role of postheparin lipases in the metabolism of high-density lipoprotein subfractions.
Chan, M K
Gemfibrozil improves abnormalities of lipid metabolism in patients on continuous ambulatory peritoneal dialysis: the role of postheparin lipases in the metabolism of high-density lipoprotein subfractions. [electronic resource] - Metabolism: clinical and experimental Oct 1989 - 939-45 p. digital
Publication Type: Journal Article
0026-0495
10.1016/0026-0495(89)90003-6 doi
Adult
Aged
Apolipoprotein A-I
Apolipoproteins A--metabolism
Apolipoproteins B--metabolism
Cholesterol--metabolism
Cholesterol, HDL--metabolism
Cholesterol, LDL--metabolism
Drug Evaluation
Female
Gemfibrozil--administration & dosage
Humans
Hyperlipidemias--prevention & control
Lipid Metabolism
Lipoprotein Lipase--metabolism
Lipoproteins, HDL--metabolism
Liver--enzymology
Male
Middle Aged
Peritoneal Dialysis, Continuous Ambulatory--adverse effects
Time Factors
Triglycerides--metabolism
Gemfibrozil improves abnormalities of lipid metabolism in patients on continuous ambulatory peritoneal dialysis: the role of postheparin lipases in the metabolism of high-density lipoprotein subfractions. [electronic resource] - Metabolism: clinical and experimental Oct 1989 - 939-45 p. digital
Publication Type: Journal Article
0026-0495
10.1016/0026-0495(89)90003-6 doi
Adult
Aged
Apolipoprotein A-I
Apolipoproteins A--metabolism
Apolipoproteins B--metabolism
Cholesterol--metabolism
Cholesterol, HDL--metabolism
Cholesterol, LDL--metabolism
Drug Evaluation
Female
Gemfibrozil--administration & dosage
Humans
Hyperlipidemias--prevention & control
Lipid Metabolism
Lipoprotein Lipase--metabolism
Lipoproteins, HDL--metabolism
Liver--enzymology
Male
Middle Aged
Peritoneal Dialysis, Continuous Ambulatory--adverse effects
Time Factors
Triglycerides--metabolism